NewAmsterdam Pharma Co N.V (NAMS) Other Non Operating Income: 2023-2025
Historic Other Non Operating Income for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Sep 2025 value amounting to $23.8 million.
- NewAmsterdam Pharma Co N.V's Other Non Operating Income rose 408.16% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.2 million, marking a year-over-year decrease of 0.73%. This contributed to the annual value of $38.6 million for FY2024, which is 285.14% up from last year.
- According to the latest figures from Q3 2025, NewAmsterdam Pharma Co N.V's Other Non Operating Income is $23.8 million, which was up 175.82% from $8.6 million recorded in Q2 2025.
- NewAmsterdam Pharma Co N.V's 5-year Other Non Operating Income high stood at $30.2 million for Q1 2024, and its period low was -$13.8 million during Q1 2025.
- For the 3-year period, NewAmsterdam Pharma Co N.V's Other Non Operating Income averaged around $7.0 million, with its median value being $4.7 million (2024).
- Data for NewAmsterdam Pharma Co N.V's Other Non Operating Income shows a peak YoY increase of 886.24% (in 2024) and a maximum YoY decrease of 9,061.11% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows NewAmsterdam Pharma Co N.V's Other Non Operating Income stood at $10.2 million in 2023, then skyrocketed by 92.33% to $19.6 million in 2024, then spiked by 408.16% to $23.8 million in 2025.
- Its last three reported values are $23.8 million in Q3 2025, $8.6 million for Q2 2025, and -$13.8 million during Q1 2025.